Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Annals of Surgery|March 20, 2024
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic CancerSamuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, et al.Annals of Surgery|January 17, 2023
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic AdenocarcinomaTimothy E Newhook, Timothy J Vreeland, James F Griffin, et al.The Oncologist|July 17, 2024
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinomaMahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, et al.Journal of the National Cancer Institute|May 18, 2023
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling studyRyan W Huey, Aakash Tushar Shah, Honey V Reddi, et al.The Lancet. Oncology|March 28, 2024
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 studyBenjamin L Musher, Eric K Rowinsky, Brandon G Smaglo, et al.Nature Medicine|January 2, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trialBenjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo, et al.NPJ Precision Oncology|February 3, 2024
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinomaAbdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, et al.Research Square|August 23, 2023
Impact of <i>KRAS</i> Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal AdenocarcinomaAbdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, et al.Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
KRAS <sup>G12D</sup> -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC PatientsValerie S LeBleu, Brandon G Smaglo, Krishnan K Mahadevan, et al.Nature Communications|September 30, 2025
Engineered exosomes with Kras<sup>G12D</sup> specific siRNA in pancreatic cancer: a phase I study with immunological correlatesValerie S Kalluri, Brandon G Smaglo, Krishnan K Mahadevan, et al.Pageof 4